Skip to main content

Table 1 Demographic and clinical characteristics of Covid-19 patients admitted to a treatment centre in the Arsi Zone, 2020–2021

From: Evaluation of health-related quality of life of Covid-19 patients: a hospital-based study in South Central Ethiopia

Demographic and clinical characteristics

Frequency (%)

Sex

 Female

159 (40.0)

 Male

239 (60.0)

Age (mean = 41.5 (SD: 18.8)

 0–24 years

83 (20.9)

 25–34

102 (25.6)

 35–44

52 (13.1)

 45–54

46 (11.6)

 55 years and above

115 (28.9)

Residence

 Rural

156 (39.0)

 Urban

242 (61.0)

Health status on admission

 Asymptomatic

95 (23.9)

 Mild

93 (23.4)

 Moderate

80 (20.0)

 Severe

130 (32.7)

Comorbidity

 Yes

179 (45.0)

 No

219 (55.0)

Type of comorbidity

 Diabetes mellitus

68 (17.1)

 Hypertension

41 (10.3)

 Asthma

33 (8.3)

 Chronic pulmonary disease

30 (7.5)

 Chronic cardiac diseases

23 (5.8)

 Malignancy

11 (2.8)

 Chronic kidney disease

7 (1.8)

 HIV/AIDS

6 (1.5)

Types of antibiotic administered

 Azithromycin only

148 (37.2)

 Azithromycin + ceftriaxone

131 (32.9)

 Azithromycin + vancomycin + ceftazidime

50 (12.6)

 Azithromycin + ceftriaxone + metronidazole

30 (7.5)

 Azithromycin + ceftriaxone + vancomycin

24 (6.0)

 Azithromycin + ceftriaxone + amoxicillin

13 (3.3)

 Azithromycin + ceftriaxone + ceftazidime

2 (0.5)

Dexamethasone used

 Yes

116 (29.1)

 No

282 (70.9)

Intranasal oxygen used

 Yes

162 (59.3)

 No

236 (40.7)

Length of hospital stay (mean = 14.3 SD:4.8)

 1–7 days

12 (3.0)

 8–14 days

248 (61.8)

 15–21 days

113 (28.4)

 22–28 days

13 (3.3)

 More than 28 days

14 (5.5)